INTERCURE LTD. Additions From Purchases Biological Assets
INTERCURE LTD. (INCR) reported Additions From Purchases Biological Assets of ILS 26.08 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-01.
Financial Statements › Notes
ifrs-full:AdditionsFromPurchasesBiologicalAssets · last filed 2025-05-01
| Period end | Additions From Purchases Biological Assets 12 month |
|---|---|
| 2024-12-31 | 26.08M ILS 20-F · filed 2025-05-01 |
| 2023-12-31 | 57.50M ILS 20-F · filed 2025-05-01 |
| 2022-12-31 | 79.13M ILS 20-F · filed 2024-05-01 |
| 2021-12-31 | 24.56M ILS 20-F · filed 2023-05-01 |
| 2020-12-31 | 10.45M ILS 20-F · filed 2022-04-28 |